Cargando…
Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report
INTRODUCTION: Serological detection of SARS-CoV-2-specific immunoglobulins G (IgG) and M (IgM) antibodies is becoming increasingly important in the management of the COVID-19 pandemic. METHODS: We report the first results of COVID-19 serological testing in Bosnia and Herzegovina on 2841 samples coll...
Autores principales: | Ašić, Adna, Prguda-Mujić, Jasminka, Salihefendić, Lana, Bešić, Larisa, Ler, Daria, Čeko, Ivana, Hadžović-Džuvo, Almira, Jažić, Sead, Konjhodžić, Rijad, Marjanović, Damir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130482/ https://www.ncbi.nlm.nih.gov/pubmed/34025854 http://dx.doi.org/10.5114/aoms/134143 |
Ejemplares similares
-
Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina—One year later
por: Prguda-Mujic, Jasminka, et al.
Publicado: (2022) -
Haplogroup Prediction Using Y-Chromosomal Short Tandem Repeats in the General Population of Bosnia and Herzegovina
por: Babić Jordamović, Naida, et al.
Publicado: (2021) -
Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections
por: Salihefendić, Lana, et al.
Publicado: (2023) -
Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: Lessons learned to optimize future molecular and epidemiological approaches
por: Goletic, Teufik, et al.
Publicado: (2021) -
Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina
por: Ašić, Adna, et al.
Publicado: (2019)